Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Aligos Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) · South San Francisco, CA, United States

  1. PrincipalsLawrence BlattPresident and CEOand 3 more
  2. CompanyAligos Therapeutics, Inc.South San Francisco, CA, United States
  3. Phone line+1 (800) 466-6059General business
Request a quote

Aligos Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker ALGS) classified under SIC 2836: Biological Products, (No Diagnostic Substances).

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions

People 4

Chief executive

Lawrence BlattPresident and CEO
Everyone else on file (3)
Julian A. SymonsOfficer (see SEC filing)
Lesley Ann CalhounOfficer (see SEC filing)
Nikhil AnejaPrincipal Accounting Officer

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Lawrence Blatt — President and CEO

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Julian A. Symons — Officer (see SEC filing)

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Lesley Ann Calhoun — Officer (see SEC filing)

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Nikhil Aneja — Principal Accounting Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers